Singapore markets closed

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
28.450.00 (0.00%)
At close: 12:56PM EDT
Show:
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
4,169,049,000
4,027,478,000
3,569,006,000
3,197,812,000
3,291,188,000
Cost of revenue
1,353,949,000
1,244,072,000
1,106,846,000
994,308,000
1,089,764,000
Gross profit
2,815,100,000
2,783,406,000
2,462,160,000
2,203,504,000
2,201,424,000
Operating expenses
Research development
695,012,000
633,325,000
526,087,000
455,833,000
492,381,000
Selling general and administrative
1,023,381,000
997,309,000
886,361,000
875,663,000
964,737,000
Total operating expenses
2,439,793,000
2,230,300,000
1,928,585,000
1,805,437,000
1,945,099,000
Operating income or loss
375,307,000
553,106,000
533,575,000
398,067,000
256,325,000
Interest expense
162,871,000
116,973,000
122,432,000
130,806,000
149,010,000
Total other income/expenses net
-36,510,000
-42,374,000
-103,831,000
106,321,000
-170,430,000
Income before tax
148,228,000
375,090,000
302,571,000
366,235,000
-60,754,000
Income tax expense
-30,099,000
58,052,000
72,405,000
-9,936,000
-105,044,000
Income from continuing operations
178,327,000
317,038,000
230,166,000
376,171,000
44,290,000
Net income
178,219,000
317,017,000
230,059,000
376,005,000
44,241,000
Net income available to common shareholders
178,219,000
317,017,000
230,059,000
376,005,000
44,241,000
Basic EPS
123.18
204.29
147.14
240.72
28.41
Diluted EPS
121.35
201.94
145.87
238.96
28.25
Basic average shares
1,557,376
1,551,809
1,563,501
1,562,006
1,557,204
Diluted average shares
1,576,431
1,569,872
1,577,169
1,573,537
1,566,204